Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.15 (8.82%)
Spread: 0.10 (5.556%)
Open: 1.75
High: 1.85
Low: 1.70
Prev. Close: 1.70
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new Strategic Advisor

21 Feb 2022 07:00

RNS Number : 1894C
Alpha Growth PLC
21 February 2022
 

21 February 2022

Alpha Growth Plc

("Alpha", or the "Company")

 

Appointment of new Strategic Advisor

 

 

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, is pleased to announce the appointment of Mark Ward as a Strategic Advisor to the Company.

 

Mark founded UK-based technology services provider Hunter Macdonald in 2013 and led its growth to circa 500 employees globally, its clients included public sector organisations such as HM Treasury, the Ministry of Defence and the Home Office, as well as private sector companies such as RBS, Airbus and Rolls-Royce .

 

In 2017, Hunter Macdonald was recognized as the UK's fastest growing IT Services company by the Sunday Times Tech Track after achieving a compounded annual growth rate of 273 per cent over three years. His company joined forces with Denmark's Netcompany group in 2017 to create a significant new pan European IT Services company which today totals over 6,000 employees.

 

Prior to founding Hunter Macdonald, Mark held senior director level roles at technology companies including Verizon and BT, as well as FTSE100 life insurance company Friends Life and leading professional services firm PwC.

 

Mark holds approximately 20.8% of the Company's issued share capital and has elected not to be compensated for this appointment.

 

Mark Ward commented:

 

"I've been invested in Alpha Growth Plc for some time now and have been hugely impressed by the rapid growth already achieved by Gobind and the Alpha team.

 

I'm very excited about the future potential of the company and I am looking forward to working with the board as we continue to grow the business and execute upon our already successful buy and build strategy.

 

A key part of my role will be opening up our investment propositions to a wider audience via innovations in insurtech, improving our digital footprint and enhancing shareholder communications."

 

Gobind Sahney, Executive Chairman of Alpha Growth Plc commented:

 

"Mark has been a very supportive shareholder and I am very pleased he has accepted my invitation to join Alpha Growth as a Strategic Advisor at this exciting time in our evolution.

 

He has a huge amount of experience scaling successful businesses and his background in M&A, technology transformation, communications and digital marketing will be invaluable as we progress a number of our key strategic growth initiatives in both our fund and insurance segments.

 

I look forward to updating our shareholder base on further company progress later this month."

 

For more information, please visit www.algwplc.com or contact the following:

 

 

Alpha Growth Plc

+44 (0) 20 3959 8600

 

Gobind Sahney, Executive Chairman 

info@algwplc.com

 

 

 

 

BlackOak Alpha Growth Funds

+1 949-326-9799

 

 

www.boagf.com

 

 

Arden Partners plc

+44 (0) 20 7614 5900

 

Ruari McGirr / Alexandra Campbell-Harris

(Corporate Finance)

 

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

 

 

 

     

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

 

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

 

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.

 

ENDS

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKFBKOBKDDBD
Date   Source Headline
21st Dec 20177:00 amRNSFirst Contract Signed
20th Dec 20177:00 amRNSFirst Day Of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.